the aid library

LIST OPTIONS

Filter

2476

Fact Sheet Hypertension

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The World Health Organization's fact sheet on hypertension provides a comprehensive overview of high blood pressure, highlighting its prevalence, risk factors, and health implications. It emphasizes that hypertension is a major cause of premature death worldwide, with an estimated 1.28 billion adult... more

Download (338)

View PDF (505)

Guideline: Vitamin D supplementation in pregnant women

World Health Organization (WHO) (2012) C_WHO

Vitamin D deficiency is thought to be common among pregnant women, particularly during the winter months, and has been found to be associated with an increased risk of pre-eclampsia, gestational diabetes mellitus, preterm birth, and other tissue-spe... more

Advisory for quarantine of migrant workers

Ministery of Health and Family Welfare - Government of India (2020) C2

Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2). Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment, the disease presentati... more

External Link

COVID-19 Resources for the Public
recommended

Knowledge Translation Unit; Western Cape South Africa (2021) CC

Posters & Infographics on different topics, i.e: vaccination, people with high risk of severe Covid-19, for families, work, school, hand hygiene, care at home, public transport

Diabetes and Ramadan: Practical guidelines 2021

Hassanein M., Afandi B. et al. Diabetes Research and Clinical Practice (2016) CC2

The document "Diabetes and Ramadan: Practical Guidelines 2021," published by Elsevier, provides updated guidance for managing diabetes during Ramadan fasting. Developed by the International ... Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance, the guidelines address key aspects for individuals with diabetes who choose to fast, including risk assessment, blood glucose monitoring, insulin and medication adjustments, and the management of special populations (such as pregnant women, the elderly, and those with chronic conditions). Emphasis is placed on individualized patient education before Ramadan to ensure safe fasting practices and minimize risks like hypoglycemia and hyperglycemia. more

Travel and Diabetes

Emirates Diabetes Society (2024) CC

Poster

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 country capacity survey in the Eastern Mediterranean Region

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The report "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases" provides an overview of the capacities of countries in the Eastern Mediterranean Region to address noncommunicable diseases (NCDs) based on a 2019 su... more

Global mapping report on multisectoral actions to strengthen the prevention and control of noncommunicable diseases and mental health conditions Experiences from around the world 2023

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The "Global mapping report on multisectoral actions to strengthen the prevention and control of noncommunicable diseases (NCDs) and mental health conditions" by the WHO provides insights into how different countries are implementing multisectoral ap... more

Use of non-sugar sweeteners: WHO guideline 2023

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The document titled "Use of Non-Sugar Sweeteners: WHO Guideline" provides recommendations from the World Health Organization on the use of non-sugar sweeteners (NSS) to reduce sugar intake, manage weight, and prevent diet-related noncommunicable diseases (NCDs). It discusses the potential effects of... more

Noncommunicable diseases - Regional framework for action

World Health Organization (WHO) Regional Office for the Eastern Mediterranean World Health Organization (WHO) Regional Office for the Eastern Mediterranean (2024) C_WHO

The WHO EMRO webpage on the "Regional framework for action" outlines strategies for addressing noncommunicable diseases (NCDs) within the Eastern Mediterranean region. The framework provides a roadmap for countries to reduce the prevalence and impact of NCDs such as cardiovascular diseases, ..., cancer, and respiratory illnesses. It emphasizes preventive measures, health promotion, and the integration of NCD management into primary healthcare systems. Key components include policy development, surveillance, and the mobilization of resources to support sustainable NCD initiatives. The framework aims to strengthen regional collaboration to improve health outcomes related to NCDs. more

Can we prevent cardiovascular diseases in low- and middle-income countries?

Lenfant, C. Bulletin of the World Health Organization (2001) C_WHO

The article "Can we prevent cardiovascular diseases in low- and middle-income countries?" by Claude Lenfant discusses the growing threat of cardiovascular diseases (CVDs) in developing countries. It highlights that while CVD is already the leading cause of death globally, low- and middle-income coun... more

ГЛОБАЛЬНЫЙ ПЛАН ДЕЙСТВИЙ ПО ПРОФИЛАКТИКЕ НЕИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ И БОРЬБЕ С НИМИ

World Health Organization (WHO) World Health Organization (WHO) (2013) C_WHO

The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, d... or chronic respiratory diseases by 2025. The main focus of this action plan is on 4 types of NCDs (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes) which make the largest contribution to morbidity and mortality due to NCDs, and on 4 shared behavioural risk factors (tobacco use, unhealthy diet, physical inactivity, harmful use of alcohol). more

Unhealthy Dietary Habits and Obesity: The Major Risk Factors Beyond Non-Communicable Diseases in the Eastern Mediterranean Region

Al-Jawaldeh, A.; Abbass, M.M. Frontiers in Nutrition (2022) CC

The article examines the nutritional and lifestyle-related risk factors contributing to the prevalence of non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and cancer in the Eastern Mediterranean Region (EMR). It highlights... more

The rising burden of non-communicable diseases in the Americas and the impact of population aging: a secondary analysis of available data

Hambleton, I. R.; Caixeta, R.; Jeyaseelan, S.M.; et al. The Lance Regional Health America (2023) CC2

The article "The Rising Burden of Non-Communicable Diseases in the Americas and the Impact of Population Aging" examines how the aging population in the Americas is contributing to the growing burden of non-communicable diseases (NCDs), despite improvements in disease ... and health care. Using data from the World Health Organization and the United Nations, the study analyzes trends in population growth, aging, and NCD-related mortality and disability rates from 2000 to 2019 across 33 countries. more

Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs)

Caprara, G. Multidisciplinary Digital Publishing Institute (MDPI) (2021) CC

The uploaded document explores the Mediterranean diet and physical activity as effective strategies to prevent and manage non-communicable diseases (NCDs). It discusses the diet's nutritional components, such as olive oil, fruits, and vegetables, and their health benefits, including reduced risk of ... more

Physical Activity - WHO

World Health Organization (WHO) World Health Organization (WHO) (2022) CC

The World Health Organization's fact sheet on physical activity emphasizes its critical role in maintaining health and well-being. It outlines the benefits of regular physical activity, such as reducing the risk of noncommunicable diseases like heart disease, stroke, ..., and certain cancers. The document provides specific recommendations for different age groups, detailing the amount and intensity of physical activity needed to achieve health benefits. It also addresses the global prevalence of physical inactivity, highlighting the need for policies and interventions to promote active lifestyles. more

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease

Institute for Health Metrics and Evaluation - University of Washington The Lancet (2017) CC2

The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a ... more

Noncommunicable diseases country profiles 2018 WHO

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO

The Noncommunicable Diseases Country Profiles 2018 by the World Health Organization (WHO) provides an in-depth look at the burden of noncommunicable diseases (NCDs) such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes ... more

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 1: conducting a comprehensive assessment

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi... more

Download (290)

View PDF (386)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

COVID-19 Resources for the Public recommended

COVID-19 Resources for the Public
recommended